Back
Cyclerion Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
55
CYCN
Cyclerion Therapeutics
Last Price:
3.40
Seasonality Move:
10.81%
Sell
23
NBY
NovaBay Pharmaceuticals
Last Price:
0.58
Seasonality Move:
-6.51%
Buy
55
Cyclerion Therapeutics (CYCN)
is a Buy
Is Cyclerion Therapeutics a Buy, Sell or Hold?
- The current Cyclerion Therapeutics [CYCN] share price is $3.43. The Score for CYCN is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CYCN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.57. The Score for NBY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CYCN Stock Price Chart
What is Cyclerion Therapeutics's stock price today?
-
The Cyclerion Therapeutics share price today is $3.43
The current trend is moderately bullish and CYCN is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.
CYCN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.4 | Buy |
Relative Strength Index (14 RSI): | 52.67 | Buy |
Chaikin Money Flow: | 34399 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.43 - 3.95) | Buy |
Bollinger Bands (100): | (2.14 - 3.5) | Buy |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 41.63 | Sell |
Chaikin Money Flow: | 40319 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.57 - 0.71) | Sell |
Bollinger Bands (100): | (0.4 - 0.86) | Sell |
CYCN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.27 | Sell |
20-day SMA: | 2.83 | Buy |
50-day SMA: | 2.7 | Buy |
200-day SMA: | 2.86 | Buy |
8-day EMA: | 3.63 | Sell |
20-day EMA: | 3.18 | Buy |
50-day EMA: | 2.86 | Buy |
200-day EMA: | 3.06 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.57 | Buy |
20-day SMA: | 0.62 | Sell |
50-day SMA: | 0.65 | Sell |
200-day SMA: | 2 | Sell |
8-day EMA: | 0.58 | Sell |
20-day EMA: | 0.61 | Sell |
50-day EMA: | 0.67 | Sell |
200-day EMA: | 4.92 | Sell |
Cyclerion Therapeutics Earnings Growth & CYCN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Cyclerion Therapeutics Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |